At the Annual General Meeting of RaySearch Laboratories AB (publ) the following resolutions were adopted:
It was resolved that no dividends would be paid out to the shareholders since the company is in a phase of rapid expansion that requires capital. The accumulated profit of SEK 20 422 000 was brought forward and balanced in the new accounts.
It was resolved to approve discharge from personal liability for the members of the Board and the President.
It was resolved that the guidelines for remuneration to senior executives adopted at the Annual General Meeting 2011 continue to apply for the period until the close of the Annual General Meeting 2013.
It was resolved that remuneration to Board members who do not receive a salary from any Group company, total SEK 640,000 for the period extending to the close of the next Annual General Meeting, of which SEK 380,000 will be paid to the Chairman and SEK 130,000 to each of the Board members elected by the Annual General Meeting, who do not receive a salary from any Group company.
It was resolved that the Auditors’ fees be paid in accordance with current approved invoicing.
It was resolved to re-elect Carl Filip Bergendal, Erik Hedlund, Johan Löf and Hans Wigzell as Board members of the company and to re-elect Erik Hedlund as Chairman of the Board.
It was resolved to adopt new Articles of Association, the only modification of which is that § 6 now reads as follows: “The company shall have at least one auditor and no more than two auditors, with or without deputy auditors. The company may appoint a registered accounting firm as auditor.” This modification means that the auditor will be appointed for the time period until the end of the first Annual General Meeting held after the year when the auditor was appointed, and that auditing firms may be appointed as auditors of the company.
It was resolved to appoint the auditing firm KPMG as auditors, with the authorized public accountant Anders Malmeby as auditor in charge and authorized public accountant Lena Krause as deputy auditor.
RaySearch Laboratories is a medical technology company that develops advanced software solutions for improved radiation therapy of cancer. RaySearch’s products are mainly sold through license agreements with leading partners such as Philips, Nucletron, IBA Dosimetry, Varian, Accuray and Siemens. To date, 15 products have been launched through partners and RaySearch’s software is used at over 2,000 clinics in more than 30 countries. In addition, RaySearch offers the proprietary treatment planning system RayStation® directly to clinics. RaySearch was founded in 2000 as a spin-off from Karolinska Institutet in Stockholm and the company is listed in the Small Cap segment on NASDAQ OMX Stockholm.
For more information about RaySearch, visit www.raysearchlabs.com
For further information, please contact:
Johan Löf, President and CEO, RaySearch Laboratories AB
Telephone: +46 (0)8-545 061 30